Viswanathan S - Search Results

1

Towards predictive models of stem cell fate.

Viswanathan S, Zandstra PW. Viswanathan S, et al. Cytotechnology. 2003 Mar;41(2-3):75-92. doi: 10.1023/A:1024866504538. Cytotechnology. 2003. PMID: 19002945 Free PMC article.

2

Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6.

Viswanathan S, Benatar T, Rose-John S, Lauffenburger DA, Zandstra PW. Viswanathan S, et al. Stem Cells. 2002;20(2):119-38. doi: 10.1634/stemcells.20-2-119. Stem Cells. 2002. PMID: 11897869

3

Supplementation-dependent differences in the rates of embryonic stem cell self-renewal, differentiation, and apoptosis.

Viswanathan S, Benatar T, Mileikovsky M, Lauffenburger DA, Nagy A, Zandstra PW. Viswanathan S, et al. Biotechnol Bioeng. 2003 Dec 5;84(5):505-17. doi: 10.1002/bit.10799. Biotechnol Bioeng. 2003. PMID: 14574685

4

Clonal evolution of stem and differentiated cells can be predicted by integrating cell-intrinsic and -extrinsic parameters.

Viswanathan S, Davey RE, Cheng D, Raghu RC, Lauffenburger DA, Zandstra PW. Viswanathan S, et al. Biotechnol Appl Biochem. 2005 Oct;42(Pt 2):119-31. doi: 10.1042/BA20040207. Biotechnol Appl Biochem. 2005. PMID: 15882145

5

Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.

Swift BE, Williams BA, Kosaka Y, Wang XH, Medin JA, Viswanathan S, Martinez-Lopez J, Keating A. Swift BE, et al. Among authors: viswanathan s. Haematologica. 2012 Jul;97(7):1020-8. doi: 10.3324/haematol.2011.054254. Epub 2012 Jan 22. Haematologica. 2012. PMID: 22271890 Free PMC article.

6

Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation.

Viswanathan S, Keating A, Deans R, Hematti P, Prockop D, Stroncek DF, Stacey G, Weiss DJ, Mason C, Rao MS. Viswanathan S, et al. Stem Cells Dev. 2014 Jun 1;23(11):1157-67. doi: 10.1089/scd.2013.0591. Epub 2014 Mar 10. Stem Cells Dev. 2014. PMID: 24422625 Free PMC article.

7

TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling.

Rashedi I, Gómez-Aristizábal A, Wang XH, Viswanathan S, Keating A. Rashedi I, et al. Among authors: viswanathan s. Stem Cells. 2017 Jan;35(1):265-275. doi: 10.1002/stem.2485. Epub 2016 Sep 20. Stem Cells. 2017. PMID: 27571579

8

A Systematic Study of the Effect of Different Molecular Weights of Hyaluronic Acid on Mesenchymal Stromal Cell-Mediated Immunomodulation.

Gómez-Aristizábal A, Kim KP, Viswanathan S. Gómez-Aristizábal A, et al. Among authors: viswanathan s. PLoS One. 2016 Jan 28;11(1):e0147868. doi: 10.1371/journal.pone.0147868. eCollection 2016. PLoS One. 2016. PMID: 26820314 Free PMC article.

9

Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency.

Robb KP, Fitzgerald JC, Barry F, Viswanathan S. Robb KP, et al. Among authors: viswanathan s. Cytotherapy. 2019 Mar;21(3):289-306. doi: 10.1016/j.jcyt.2018.10.014. Epub 2018 Dec 6. Cytotherapy. 2019. PMID: 30528726 Review.

10

Overcoming the challenges of conducting translational research in cell therapy.

Viswanathan S, Keating A. Viswanathan S, et al. Front Med. 2011 Dec;5(4):333-5. doi: 10.1007/s11684-011-0166-2. Epub 2011 Dec 27. Front Med. 2011. PMID: 22198744 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results